ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,872, issued on July 8, was assigned to Adaptive Biotechnologies Corp. (Seattle).
"Determining antigen-specific T-cells" was invented by Mark Klinger (Seattle) and Malek Faham (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is directed to methods for determining antigen-specific T cells. In some embodiments, methods of the inven-tion may be implemented by the steps of reacting under interaction conditions one or more antigens with T cells in a plurality of subsets of a tissue sample, such as peripheral blood; sorting antigen-interacting T cells from other T cells; separately sequencing for each subset recombined nucleic acid enco...